# Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI

> **NCT06663228** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MMS

## Key facts

- **NCT ID:** NCT06663228
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-17
- **Primary completion:** 2025-07-04
- **Final completion:** 2025-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06663228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06663228, "Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06663228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*